Atlas Trials

Safety and Immunogenicity of PCV-LITE, a Low-dose of Pneumococcal Conjugate Vaccine With LiteVax Adjuvant

Clinical trial NCT06986239 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06986239
Sponsor
LiteVax BV
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Vaccine Reaction
Start date
2025-07-01
Primary completion
2026-04-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.